USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Global Decentralized Clinical Trials Growth Opportunities
Strong Competitive Intensity is Advancing DCT Initiatives Across the World Paving Way for a Partnership-based Growth Model
15-Sep-2023
North America
Market Research
PF10-01-00-00-00
HC_2023_142
$4,950.00
Special Price $3,712.50 save 25 %
The global decentralized clinical trial (DCT) market has been witnessing a continued surge after the COVID-19 pandemic. The accelerated DCT adoption in 2020 was driven by restricted mobility of site investigators, clinical research associates, and patients to participate in trials, which resulted in a significant halt in trial activities worldwide. To ensure patient safety and continuity in the R&D activities, most sponsors and contract research organizations (CROs) adopted digital tools to support trial operations, including telemedicine, remote source data verification, and sensor/mobile technology-enabled direct data-capture solutions.
Regulatory agencies around the world are coming up with initiatives and guidelines for large-scale adoption of DCT modalities, alongside existing alliances, such as Decentralized Trials & Research Alliance (DTRA), that work toward increasing DCT awareness, propelling remote trial uptake.
North America continues to lead the DCT market owing to a strong presence of DCT vendors, CROs, and pharma sponsors in the region, followed closely by Europe, which has abundant infrastructure for large-scale DCT uptake. Nevertheless, Asia-Pacific is emerging as a crucial region with several leading global CROs establishing strong bases due to patient diversity, treatment-naive population, and significant cost advantage. In addition, there is a growing reliance on telemedicine and ePharmacy solutions in the region, which will propel DCT uptake in 3 to 5 years. In the Rest of World region, the Middle East is gearing up for greater remote trial adoption, with Kingdom of Saudi Arabia and Dubai at the forefront. Several tech vendors, such as Oracle and AWS, have set up bases in the region to allow the uptake of eClinical solutions, promoting growth. However, at present, the market will have comparatively slower growth than other regions.
There will be a constant need to support decentralized trials through cloud-based platform solutions that are fit to purpose. Therefore, CROs are building decentralized trial capabilities by partnering with technology vendors. In addition, online training modules for patients and secure technology for at-home trial monitoring through devices, chatbots, and sensors have been driving the adoption of decentralized trials after the pandemic.
Home health services for patients with physical disabilities and restricted access due to location can promote retention in clinical trials. Partnering with home health service providers supported by nurses trained in portable equipment usage will facilitate smooth DCT implementation. In addition, CROs are focused on innovating trial enrollment and patient engagement strategies by exploring multiple channels, such as the use of advocacy groups, social media, and online physician referral systems, as well as implementing AI-enabled platforms, expanding the DCT ecosystem.
Author: Aarti Siddhesh Chitale
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Decentralized Clinical Trial (DCT) Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Decentralized Clinical Trials Market Segmentation
Growth Metrics
Comparison of Traditional and Decentralized Clinical Trials
DCT Value Proposition: Achieving Patient Centricity
Decentralized Clinical Trials: Pharma Ecosystem
Decentralized Clinical Trials: Patient Ecosystem
Market Trend Analysis
Evolving DCT Landscape
Global DCT Initiatives and Guidelines
Global DCT Initiatives and Guidelines (continued)
Global DCT Initiatives and Guidelines (continued)
Global DCT Initiatives and Guidelines (continued)
Implications of DCT Initiatives on the Global DCT Market
Implications of DCT Initiatives on Individual Stakeholders
Growth Drivers
Growth Restraints
DCT: Evolving Vendor Ecosystem
DCT: Evolving Vendor Ecosystem (continued)
DCT: Evolving Vendor Ecosystem (continued)
Business Model Trend: Global DCT Market
Partnership Trends Driving DCT Business Models
Strategic Partnerships in DCT Market
Strategic Partnerships in DCT Market (continued)
Strategic Partnerships in DCT Market (continued)
Strategic Partnerships in DCT Market (continued)
Strategic Partnerships in DCT Market (continued)
Strategic Partnerships in DCT Market (continued)
Key Mergers and Acquisitions
New Platform Launches
New Platform Launches (continued)
Forecast Assumptions
Forecast Assumptions (continued)
Revenue Forecast: Global
Revenue Forecast Analysis
Revenue Forecast Analysis (continued)
Revenue Forecast Analysis (continued)
Revenue Forecast by Phases of Clinical Development
Revenue Percentage by Phase of Development
Revenue Forecast by Clinical Development Phases
Revenue Share Analysis by Therapy Areas
Revenue Share Analysis by Therapy Areas
Revenue Share Analysis by Therapy Areas (continued)
Revenue Forecast by Regions
Revenue Forecast Analysis by Region: DCT Market
Revenue Forecast Analysis: North America
Revenue Forecast Analysis: Europe
Revenue Forecast Analysis: Asia-Pacific (APAC)
Revenue Forecast Analysis: Rest of World (RoW)
Competitive Environment
Competitor Benchmarking: Pure-play DCT Vendors
Competitor Benchmarking: CROs (Enablers/DCT Vendors)
Competitor Benchmarking: DCT Enablers
Competitor Assessment
Competitor Assessment (continued)
Growth Opportunity 1: Endpoint Assessment with Digital Biomarkers
Growth Opportunity 1: Endpoint Assessment with Digital Biomarkers (continued)
Growth Opportunity 2: Digital Health Technology (DHT)-enabled Focus on Oncology Trials
Growth Opportunity 2: Digital Health Technology (DHT)-enabled Focus on Oncology Trials (continued)
Growth Opportunity 3: Adopting Partnership-based Approaches for Scaling DCT Capabilities
Growth Opportunity 3: Adopting Partnership-based Approaches for Scaling DCT Capabilities (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
List of Figures
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
26 Aug 2026 | Global | Technology Research
Growth Opportunities and Advancements in Acute and Chronic Wound Care
A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...
26 Aug 2026 | Global | Frost Radar
Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026
Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...
25 Aug 2026 | Global | Technology Research
Breakthrough Innovations in Point-of-Care Diagnostics
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.
The study assesses key technology shifts, including rapid molecular t...
25 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Digital Biomarkers
A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications.
These biomarkers provide continuous, real-time insights into an ...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Aarti Siddhesh Chitale |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Clinical Trial Technology |
| Keyword 2 | Remote Patient Monitoring |
| Keyword 3 | Clinical Trial Decentralization |
| List of Charts and Figures | DCT Market: Growth Metrics, Global, 2022 DCT Market: Growth Drivers, Global, 2023–2028 DCT Market: Growth Restraints, Global, 2023–2028 DCT Market: Evolving Business Model, Global, 2023–2028 DCT Market: Revenue Forecast, Global, 2020–2028 DCT Market: Revenue Forecast by Phase of Clinical Development, Global, 2020–2028 DCT Market: Revenue Percentage by Phase of Development, Global, 2020–2028 DCT Market: Revenue Share Analysis by Therapy Areas, Global, 2022 DCT Market: Revenue Forecast by Region, Global, 2020–2028 DCT Market: Regional Analysis, Global, 2022–2028 |
| Podcast | No |
| WIP Number | PF10-01-00-00-00 |